Interleukin-12 anchored drug conjugate (tolododekin alfa) in patients with advanced solid tumors: first-in-human Phase 1 trial
J
Jong Chul Park
B
Brendan Curti
M
Marcus Butler
E
Eric Wehrenberg-Klee
J
Joseph Elassal
R
Robert Tighe
S
Sailaja Battula
G
Gail Iodice
H
Howard L. Kaufman
J
John M. Kirkwood
Article Details
Journal
Nature Communications
Volume / Issue
Vol. 16, Issue 1
Published
September 29, 2025
ISSN
2041-1723
Publisher
Nature Portfolio
Authors (10)
J
Jong Chul Park
B
Brendan Curti
M
Marcus Butler
E
Eric Wehrenberg-Klee
J
Joseph Elassal
R
Robert Tighe
S
Sailaja Battula
G
Gail Iodice
H
Howard L. Kaufman
J
John M. Kirkwood
Related Articles from this Journal
Synthesis of adaptive 15N-nitrosyl-Co7 nanocluster for electrocatalytic C–H functionalization
Chao Wu, Xu Zhang et al.
Aug 2026
10.1038/s41467-026-76516-1
Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses
Connor Weidle, Natalie Brunette et al.
Aug 2026
10.1038/s41467-026-76114-1
Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk
Ludmila Prokunina-Olsson, Oscar Florez-Vargas et al.
Aug 2026
10.1038/s41467-026-76157-4
Genome-wide annotation of human multi-nucleotide variants reveals widespread functional differences from single nucleotide variants
Weiwei Jin, Wen Cao et al.
Aug 2026
10.1038/s41467-026-76470-y
Allele-specific chromatin architecture shapes imprinted domains and coordinates a distal enhancer and antisense transcription at the mouse Mest-Copg2 domain
Bongmin Bae, Katherine Gu et al.
Aug 2026
10.1038/s41467-026-76506-3